C4 Therapeutics (CCCC) Payables (2019 - 2025)
C4 Therapeutics (CCCC) has 7 years of Payables data on record, last reported at $858000.0 in Q4 2025.
- For Q4 2025, Payables fell 35.39% year-over-year to $858000.0; the TTM value through Dec 2025 reached $858000.0, down 35.39%, while the annual FY2025 figure was $858000.0, 35.39% down from the prior year.
- Payables reached $858000.0 in Q4 2025 per CCCC's latest filing, down from $1.3 million in the prior quarter.
- Across five years, Payables topped out at $4.5 million in Q4 2021 and bottomed at $683000.0 in Q1 2025.
- Average Payables over 5 years is $2.2 million, with a median of $1.6 million recorded in 2024.
- Peak YoY movement for Payables: crashed 73.99% in 2022, then soared 142.72% in 2025.
- A 5-year view of Payables shows it stood at $4.5 million in 2021, then plummeted by 73.99% to $1.2 million in 2022, then increased by 23.38% to $1.4 million in 2023, then dropped by 8.16% to $1.3 million in 2024, then plummeted by 35.39% to $858000.0 in 2025.
- Per Business Quant database, its latest 3 readings for Payables were $858000.0 in Q4 2025, $1.3 million in Q3 2025, and $2.2 million in Q2 2025.